Ledger.Open graph →
SEC Form D · Amendment · filed February 11, 2014

Vantix Diagnostics, Inc

Offering
$16.0M
Sold
$4.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PELHAM, NH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Steve Lufkin · Pelham, NHExec · Director · PromoterDoug Armstrong · Pelham, NHDirectorRichard Wardle · Pelham, NHDirectorAnthony Pintsopoulos · Lauderdale by the Sea, FLPromoterRichard Rappaport · Lauderdale by the Sea, FLPromoterJohn E. Price · Houston, TXExec · Director · PromoterAdam L. Thomas · Houston, TXDirectorJeremy L. Radcliffe · Houston, TXDirectorLee G. Partridge · Houston, TXPromoterJohn A. Blaisdell · Houston, TXPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗